Skip to main content
Addgene

pGL3-B-pGAS5
(Plasmid #46371)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 46371 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pGL3-Basic
  • Backbone manufacturer
    promega
  • Backbone size w/o insert (bp) 4818
  • Total vector size (bp) 5700
  • Vector type
    Luciferase

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    GAS5
  • Alt name
    growth arrest-specific 5 (non-protein coding)
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    837
  • Mutation
    promoter
  • GenBank ID
    60674
  • Entrez Gene
    GAS5 (a.k.a. NCRNA00030, SNHG2)
  • Tag / Fusion Protein
    • luciferase (C terminal on backbone)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site NheI (not destroyed)
  • 3′ cloning site HindIII (not destroyed)
  • 5′ sequencing primer RVprimer3
  • 3′ sequencing primer LucNrev
  • (Common Sequencing Primers)

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

This promoter from a cancer line expressing high levels of GAS5 and contains two mismatches in the GAS5 region.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pGL3-B-pGAS5 was a gift from Emanuela Felley-Bosco & Rolf Stahel (Addgene plasmid # 46371 ; http://n2t.net/addgene:46371 ; RRID:Addgene_46371)
  • For your References section:

    GAS5 long non-coding RNA in malignant pleural mesothelioma. Renganathan A, Kresoja-Rakic J, Echeverry N, Ziltener G, Vrugt B, Opitz I, Stahel RA, Felley-Bosco E. Mol Cancer. 2014 May 23;13:119. doi: 10.1186/1476-4598-13-119. 10.1186/1476-4598-13-119 PubMed 24885398